Skip to main navigation Skip to search Skip to main content

miR-1294 Upregulation as a Diagnostic Biomarker for Cholangiocarcinoma

  • Kittiya Supradit
  • , Teva Phanaksri
  • , Sattrachai Prasopdee
  • , Sithichoke Tangphatsornruang
  • , Duangjai Sangsrakru
  • , Kanokpan Wongprasert
  • , Montinee Pholhelm
  • , Kritiya Butthongkomvong
  • , Jutharat Kulsantiwong
  • , Anthicha Kunjantarachot
  • , Veerachai Thitapakorn
  • Ramkhamhaeng University
  • Thammasat University
  • National Science and Technology Development Agency (NSTDA)
  • Mahidol University
  • Udonthani Cancer Hospital
  • Udon Thani Rajabhat University

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: To investigate plasma miR-1294 levels in cholangiocarcinoma (CCA) patients compared with healthy individuals and Opisthorchis viverrini-infected subjects. Methods: To assess its potential as a plasma-based diagnostic biomarker, plasma samples were collected and total RNA was extracted from 15 healthy controls (HC), 12 O. viverrini (OV)-infected individuals, and 33 patients with CCA. miR-1294 expression was quantified using RT-qPCR (MiRXES). Results: Relative expression analysis demonstrated a significant upregulation of plasma miR-1294 in patients with CCA compared with both HC and OV groups (P < 0.0001). Receiver operating characteristic (ROC) curve analysis showed that miR-1294 discriminated CCA from non-CCA subjects, yielding an area under the curve (AUC) of 0.8676, with a specificity of 96.30% and a sensitivity of 63.64%. Conclusion: The upregulation of plasma miR-1294 was investigated in this study. Despite these promising findings, the moderate sensitivity suggests that miR-1294 alone may not be sufficient as a standalone diagnostic marker. Nevertheless, its high specificity and non-invasive detectability highlight its potential utility as a complementary biomarker, particularly in combination with other diagnostic indicators for improved detection of CCA.

Original languageEnglish
Pages (from-to)2871-2877
Number of pages7
JournalAsian Pacific Journal of Cancer Prevention
Volume27
Issue number8
DOIs
Publication statusPublished - Aug 2026
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Opisthorchis viverrini
  • cholangiocarcinoma
  • diagnosis
  • miR-1294

Fingerprint

Dive into the research topics of 'miR-1294 Upregulation as a Diagnostic Biomarker for Cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this